Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
CNS Drugs
Metadata
Title
Advances in ADHD Treatment: A Focus on the Role of Noradrenergic and Alpha-2a Receptor Modulation
Project ID: 5964-ES-37
Publication date
01-11-2009
Publisher
Springer International Publishing
Published in
CNS Drugs / Issue Special Issue 1/2009
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.2165/00023210-200923000-00008

Other articles of this Special Issue 1/2009

CNS Drugs 1/2009 Go to the issue

Review Article

Issues in the Management of Patients with Complex Attention-Deficit Hyperactivity Disorder Symptoms

CME Post-test

Post-Test Questions

CME Overview

Advances in Attention-Deficit Hyperactivity Disorder Treatment

Review Article

Toward a New Understanding of Attention-Deficit Hyperactivity Disorder Pathophysiology

Introduction

Toward a New Understanding of Attention-Deficit Hyperactivity Disorder

Review Article

Alpha-2 Adrenergic Agonists in Children with Inattention, Hyperactivity and Impulsiveness